A detailed history of Moody National Bank Trust Division transactions in Alkermes Plc. stock. As of the latest transaction made, Moody National Bank Trust Division holds 20,995 shares of ALKS stock, worth $591,849. This represents 0.06% of its overall portfolio holdings.

Number of Shares
20,995
Previous 18,081 16.12%
Holding current value
$591,849
Previous $435,000 34.94%
% of portfolio
0.06%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$23.01 - $28.55 $67,051 - $83,194
2,914 Added 16.12%
20,995 $587,000
Q4 2023

Jan 11, 2024

BUY
$23.37 - $28.68 $69,245 - $84,978
2,963 Added 19.6%
18,081 $501,000
Q3 2023

Oct 12, 2023

BUY
$27.17 - $31.97 $76,157 - $89,611
2,803 Added 22.76%
15,118 $423,000
Q1 2023

Apr 19, 2023

BUY
$25.31 - $29.02 $110,351 - $126,527
4,360 Added 54.81%
12,315 $347,000
Q4 2022

Jan 11, 2023

BUY
$21.94 - $26.24 $174,532 - $208,739
7,955 New
7,955 $208,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.63B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Moody National Bank Trust Division Portfolio

Follow Moody National Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.